Table 3.
Larvicide | Daya | Effect of treatment compared to control |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Early instars |
Late instars |
Pupae |
||||||||
T1 | T2 | T3 | T1 | T2 | T3 | T1 | T2 | T3 | ||
Bti | 1 | ns | 0.0013 | 0.0041 | 0.0041 | 0.0041 | 0.0181 | ns | ns | ns |
2 | 0.0192 | ns | 0.0457 | 0.0113 | 0.0010 | 0.0175 | ns | 0.0225 | 0.0225 | |
3 | ns | 0.0221 | ns | 0.0013 | 0.0066 | 0.0173 | ns | ns | ns | |
4 | ns | 0.0382 | ns | 0.0013 | 0.0013 | 0.0173 | ns | 0.0225 | 0.0225 | |
5 | ns | ns | ns | ns | 0.0410 | 0.0330 | 0.0225 | 0.0225 | 0.0225 | |
6 | ns | ns | ns | 0.0410 | ns | ns | ns | 0.0225 | 0.0225 | |
7 | ns | ns | ns | 0.0010 | 0.0260 | 0.0260 | ns | ns | ns | |
8 | ns | ns | ns | 0.0100 | 0.0040 | ns | ns | ns | ns | |
9 | ns | 0.004 | ns | ns | 0.0120 | 0.0280 | ns | ns | ns | |
10 | ns | ns | ns | 0.0220 | 0.0281 | 0.0070 | ns | ns | ns | |
Bs | 1 | 0.0032 | 0.0032 | 0.0032 | 0.0032 | 0.0032 | 0.0106 | ns | ns | 0.0144 |
2 | 0.0342 | 0.0318 | 0.0032 | 0.0032 | 0.0032 | 0.0032 | 0.0363 | 0.0363 | 0.0363 | |
3 | ns | ns | ns | 0.0318 | ns | 0.0106 | ns | 0.0363 | 0.0363 | |
4 | ns | ns | ns | 0.0382 | 0.0032 | 0.0032 | 0.0363 | 0.0363 | ns | |
5 | ns | ns | ns | ns | ns | ns | 0.0363 | 0.0363 | 0.0363 | |
6 | ns | ns | 0.0267 | 0.0224 | ns | ns | 0.0363 | 0.0363 | 0.0363 | |
7 | ns | ns | ns | 0.0295 | ns | ns | ns | 0.0363 | 0.0363 | |
8 | ns | ns | ns | 0.0106 | 0.0032 | 0.0451 | ns | 0.0363 | ns | |
9 | ns | ns | ns | ns | 0.0106 | ns | ns | ns | ns | |
10 | ns | ns | ns | ns | ns | ns | 0.0091 | ns | ns |
Abbreviations: T1, minimum label rate; T2, maximum label rate; T3, twice the maximum label rate for the respective Bti and Bs trials; ns, not significant (P > 0.05).
Days post-treatment.